Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-20-015266
Filing Date
2020-06-18
Accepted
2020-06-18 16:31:49
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 f424b5061720_actinium.htm 424B5 947285
2 GRAPHIC img_02.jpg GRAPHIC 49698
3 GRAPHIC img_01.jpg GRAPHIC 11393
4 GRAPHIC img_03.jpg GRAPHIC 49698
  Complete submission text file 0001213900-20-015266.txt   1101357
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-216748 | Film No.: 20972972
SIC: 2834 Pharmaceutical Preparations